A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Biohaven Therapeutics Ltd.
- Study ID
- NCT06132893
- Phase
- PHASE2/PHASE3
- Status
- Recruiting
Conditions
- Focal Epilepsy
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- BHV-7000 — DRUGBHV-7000 25 mg. Participants will take blinded investigational product (IP) once daily
- BHV-7000 — DRUGBHV-7000 50 mg. Participants will take blinded investigational product (IP) once daily
- Placebo — DRUGMatching placebo taken once daily
- BHV-7000 — DRUGBHV-7000 75 mg. Participants willtake blinded investigational product(IP) once daily
- Placebo — DRUGMatching placebo taken once daily
Study Details
The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.
Key Dates
- Start date
- Mar 14, 2024
- Status verified
- Apr 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 390 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- TREATMENT
Arms
- Experimental: BHV-7000 25 mg Part A
- Experimental: BHV-7000 50 mg Part A
- Placebo Comparator: Placebo Part A
- Experimental: BHV-7000 75 mg Part B
- Placebo Comparator: Placebo Part B
Primary Outcome Measure
Part B: Change from Baseline in 28-day average seizure frequency [ Time Frame: Baseline, Week 8 to Week 20 of Part B ]
Central Contacts
- Chief Medical Officer203-404-0410
Locations (61)
Find similar trials in Phoenix, AZ
Related Studies
- Diffusion MRI Methods to Minimize Postoperative Deficits in Pediatric Epilepsy SurgeryRecruiting · Wayne State University · Detroit, Michigan
- Study of Transcranial Direct Current Stimulation to Treat EpilepsyRecruiting · Mayo Clinic · Rochester, Minnesota
- An Open-label Study of XEN1101 in EpilepsyPHASE3 · Enrolling By Invitation · Xenon Pharmaceuticals Inc. · Phoenix, Arizona
- Sleep Architecture & Cognition in Focal EpilepsyRecruiting · University of California, Davis · Sacramento, California